The Next Generation Research Grant in ASL and Related Disorders, funded by the CReATe Consortium and the American Brain Foundation, supports early-career researchers who are studying disease mechanisms, diagnosis, or treatment of ALS and related disorders, and whose research has potential relevance beyond ALS to other diseases. This award supports clinical or preclinical research in amyotrophic lateral sclerosis (ALS) and related disorders, including progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), frontotemporal dementia (FTD), hereditary spastic paraplegia (HSP), and multi-system proteinopathy (MSP).
Applications must meet all the following eligibility requirements:
- Applicants must be clinician-investigators with an MD, PhD, or equivalent terminal-level clinical or research degree.
- Applicants must have completed a clinical residency or a PhD within the past 4 years.
- Applicants at accredited USA and international institutions are eligible to apply. There is no citizenship requirement.
The funding provides 150,000 USD over two years, for direct costs only.
Applications close on October 8, 2026.